How Korea Can Avoid Pitfalls Of Over-Reliance On Out-Licensing

Citeline’s Pang Suggests Diverse Business Models For Korean Biopharma

 
• By Jung Won Shin
  
Citeline's Timothy Pang
Decline In Alliances Globally And In Korea As Pandemic Unwinds • Source: Jung Won Shin

More from South Korea

More from Focus On Asia